You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

tumor of interstitial cells of Cajal (ICC)

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Diabetic Gastroparesis Trial

Not yet recruiting
  • Diabetic Gastroparesis
    • (no location specified)
    Jan 13, 2023

    Advanced Intrahepatic Cholangiocarcinoma Trial in Shanghai (Cryoablation, Sintilimab, Lenvatinib)

    Recruiting
    • Advanced Intrahepatic Cholangiocarcinoma
    • Cryoablation
    • +2 more
    • Shanghai, Shanghai, China
      Fudan University Shanghai Cancer Center
    Apr 28, 2023

    Pathological Features of Achalasia and Prognosis of Per-oral

    Recruiting
    • Esophageal Achalasia
      • Beijing, Beijing, China
        Beijing Friendship Hospital
      May 24, 2022

      Gastric GIST Trial (Endoscopic resection, Laparoscopic partial gastrectomy)

      Not yet recruiting
      • Gastric GIST
      • Endoscopic resection
      • Laparoscopic partial gastrectomy
      • (no location specified)
      Nov 29, 2021

      Liver and Intrahepatic Bile Duct Carcinoma, Stage III Intrahepatic Cholangiocarcinoma AJCC v8, Stage IIIA Intrahepatic

      Recruiting
      • Liver and Intrahepatic Bile Duct Carcinoma
      • +5 more
      • Portland, Oregon
        OHSU Knight Cancer Institute
      Oct 11, 2022

      Unresectable Intrahepatic Cholangiocarcinoma Trial (Camrelizumab, Gemcitabine Injection, Cisplatin injection)

      Not yet recruiting
      • Unresectable Intrahepatic Cholangiocarcinoma
      • (no location specified)
      Feb 17, 2023

      Cholangiocarcinoma Trial in Beijing (autologous Tcm cellular immunotherapy)

      Recruiting
      • Cholangiocarcinoma
      • autologous Tcm cellular immunotherapy
      • Beijing, China
        Peking Union Medical College Hospital
      Apr 24, 2022

      Oncology Trial in Berlin (moderate Whole Body Hyperthermia (mWBH))

      Recruiting
      • Oncology
      • moderate Whole Body Hyperthermia (mWBH)
      • Berlin, Germany
        Klinik für Radioonkologie und Strahlentherapie
      Apr 6, 2023

      Intrahepatic Cholangiocarcinoma Trial in Hangzhou (Tislelizumab combined with GEMOX (GOT) regimen)

      Not yet recruiting
      • Intrahepatic Cholangiocarcinoma
      • Tislelizumab combined with GEMOX (GOT) regimen
      • Hangzhou, Zhejiang, China
        1# Banshan East Rd. Zhejiang cancer hospital
      Sep 24, 2022

      IDH Family Wildtype, Recurrent Anaplastic Astrocytoma, Recurrent Glioblastoma Trial in Houston (Laser Interstitial Thermal

      Terminated
      Has Results
      • IDH Family Wildtype
      • +2 more
      • Houston, Texas
        M D Anderson Cancer Center
      Jul 14, 2022

      Hepatocellular Cancer Trial in Clichy (IRM with a 5-minute- additional sequence to measure FRM)

      Completed
      • Hepatocellular Cancer
      • IRM with a 5-minute- additional sequence to measure FRM
      • Clichy, France
        Valérie Vilgrain
      Jun 20, 2022

      Histiocytosis Trial in Beijing (68Ga-FAPI)

      Not yet recruiting
      • Histiocytosis
      • 68Ga-FAPI
      • Beijing, China
        Department of Nuclear Medicine, Peking Union Medical College Hop
      Mar 25, 2023

      Cholangiocarcinoma Trial in Birmingham (Novel combination of chemo and immunotherapy)

      Recruiting
      • Cholangiocarcinoma
      • Novel combination of chemotherapy and immunotherapy
      • Birmingham, Alabama
        University of Alabama at Birmingham
      Jul 28, 2022

      Prostate Cancer Trial in Canada, United States (Brachytherapy (100/110), Brachytherapy (125/145), External Beam Radiation

      Unknown status
      Has Results
      • Prostate Cancer
      • Brachytherapy (100/110)
      • +2 more
      • Phoenix, Arizona
      • +169 more
      Nov 2, 2021

      Breast Tumors Trial in Nottingham (Immunostimulating Interstitial Laser Thermotherapy)

      Terminated
      • Breast Neoplasms
      • Immunostimulating Interstitial Laser Thermotherapy
      • Nottingham, United Kingdom
        Nottingham Breast Cancer Institute
      Jul 2, 2021

      Intrahepatic Cholangiocarcinoma Trial in GuangZhou (HAIC Combined with Tislelizumab and Apatinib)

      Recruiting
      • Intrahepatic Cholangiocarcinoma
      • HAIC Combined with Tislelizumab and Apatinib
      • GuangZhou, Guangdong, China
        Sun Yat-sen University Cancer Center
      Aug 4, 2022

      Melanoma, Non-small Cell Lung Carcinoma (NSCLC), Renal Cell Carcinoma (RCC) Trial in Gainesville, Jacksonville (LITT +

      Recruiting
      • Melanoma
      • +14 more
      • LITT + Pembrolizumab
      • Gainesville, Florida
      • +1 more
      Aug 22, 2022

      Idiopathic Inflammatory Myopathy, Interstitial Lung Disease Trial in Xi'an (Mycophenolate Mofetil)

      Recruiting
      • Idiopathic Inflammatory Myopathy
      • Interstitial Lung Disease
      • Mycophenolate Mofetil
      • Xi'an, China
        Department of Rheumatology,the First Affiliated Hospital of Xi'a
      Nov 10, 2021

      Hepatocellular Carcinoma Trial in Xi'an (Recombinant Human Adenovirus Type 5 injection, Sorafenib)

      Active, not recruiting
      • Hepatocellular Carcinoma
      • Recombinant Human Adenovirus Type 5 injection
      • Sorafenib
      • Xi'an, Shaanxi, China
      • +3 more
      Jan 25, 2022

      Intrahepatic Cholangiocarcinoma Trial in Guangzhou (HAIC Combined with Tislelizumab and Apatinib)

      Recruiting
      • Intrahepatic Cholangiocarcinoma
      • HAIC Combined with Tislelizumab and Apatinib
      • Guangzhou, Guangdong, China
        Sun Yat-Sen University Cancer Center
      May 28, 2022

      Cholangiocarcinoma, Intrahepatic Trial in Shanghai (Capecitabine, PD-1 Antibody(Tislelizumab))

      Recruiting
      • Cholangiocarcinoma, Intrahepatic
      • Shanghai, China
        Lulu@Huashan.Org.Cn
      Aug 16, 2022

      Predict Efficacy of GC in Treatment of Intrahepatic

      Not yet recruiting
      • Organoids
      • Intrahepatic Cholangiocarcinoma
      • gemcitabine + cisplatin
      • (no location specified)
      Nov 30, 2022

      Enteric Neural Precursor Cells (ENPC) in the Human Gut

      Recruiting
      • Gastrointestinal Dysmotility
      • Endoscopic procedure
      • Baltimore, Maryland
        Johns Hopkins Bayview Medical Center
      Mar 8, 2022

      /or PD-1 Inhibitors for Unresectable Intrahepatic

      Completed
      • Intrahepatic Cholangiocarcinoma
      • hepatic arterial infusion chemotherapy (HAIC) of oxaliplatin, fluorouracil, and leucovorin (FOLFOX)
      • GuangZhou, Guangdong, China
        Sun Yat-sen University Cancer Center
      Aug 7, 2022

      Intrahepatic Cholangiocarcinoma Trial in Philadelphia (Perflutren Protein-Type A Microspheres, Contrast-Enhanced Ultrasound)

      Recruiting
      • Intrahepatic Cholangiocarcinoma
      • Perflutren Protein-Type A Microspheres
      • Contrast-Enhanced Ultrasound
      • Philadelphia, Pennsylvania
        Sidney Kimmel Cancer Center at Thomas Jefferson University
      Apr 7, 2022